MRC-LMB Crystallisation Facility: Screen formulations developed at the LMB

• The MORPHEUS protein crystallization screen (LMB17).
• The MORPHEUS II protein crystallization screen (LMB20).
• The LMB sparse matrix (LMB21).
• The FUSION protein crystallization screen (LMB23).

More information can be found on Fabrice’s Protein Crystallisation Website.

The crystallisation screens developped at the LMB are commercialized by Molecular Dimensions under an exclusive licence from the MRC.

Back to Main Page

Last Updated 04/06/2026